{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:15:54Z","timestamp":1767960954843,"version":"3.49.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,11,1]]},"DOI":"10.1093\/ndt\/16.11.2152","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:42:52Z","timestamp":1027723372000},"page":"2152-2157","source":"Crossref","is-referenced-by-count":63,"title":["Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease"],"prefix":"10.1093","volume":"16","author":[{"given":"Marjan A.","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan M.","family":"Kamper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"van Veen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H. M.","family":"Souverijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard J.","family":"Blauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,11]]},"reference":[{"key":"key\n\t\t\t\t20180110092209_R1","doi-asserted-by":"crossref","unstructured":"Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, Ritz E. Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int1992; 42: 1259\u20131265","DOI":"10.1038\/ki.1992.413"},{"key":"key\n\t\t\t\t20180110092209_R2","doi-asserted-by":"crossref","unstructured":"Kovacs J, Gomba S. Analysis of the role of apoptosis and cell proliferation in renal cystic disorders. Kidney Blood Press Res1998; 21: 325\u2013328","DOI":"10.1159\/000025889"},{"key":"key\n\t\t\t\t20180110092209_R3","unstructured":"Carone FA, Makino H, Kanwar YS. Basement membrane antigens in renal polycystic disease. Am J Pathol1988; 130: 466\u2013471"},{"key":"key\n\t\t\t\t20180110092209_R4","doi-asserted-by":"crossref","unstructured":"Gabow PA, Johnson AM, Kaehny WD et al. Factors affecting the progression of renal disease in autosomal\u2010dominant polycystic kidney disease. Kidney Int1992; 41: 1311\u20131319","DOI":"10.1038\/ki.1992.195"},{"key":"key\n\t\t\t\t20180110092209_R5","doi-asserted-by":"crossref","unstructured":"Choukroun G, Itakura Y, Albouze G et al. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol1995; 6: 1634\u20131642","DOI":"10.1681\/ASN.V661634"},{"key":"key\n\t\t\t\t20180110092209_R6","unstructured":"Chapman AB, Schrier RW. Pathogenesis of hypertension in autosomal dominant polycystic kidney disease. Semin Nephrol1991; 11: 653\u2013660"},{"key":"key\n\t\t\t\t20180110092209_R7","doi-asserted-by":"crossref","unstructured":"Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. Kidney Int1994; 46: 1118\u20131123","DOI":"10.1038\/ki.1994.374"},{"key":"key\n\t\t\t\t20180110092209_R8","unstructured":"Barendregt JNM, Florijn KW, Muizert Y, Chang PC. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion. Nephrol Dial Transplant1995; 10: 1332\u20131341"},{"key":"key\n\t\t\t\t20180110092209_R9","doi-asserted-by":"crossref","unstructured":"Hocher B, Zart R, Schwarz A et al. Renal endothelin system in polycystic kidney disease. J Am Soc Nephrol1998; 9: 1169\u20131177","DOI":"10.1681\/ASN.V971169"},{"key":"key\n\t\t\t\t20180110092209_R10","unstructured":"Lee SK, Jin SY, Han DC, Hwang SD, Lee HB. Effects of delayed treatment with enalapril and\/or lovastatin on the progression of glomerulosclerosis in 5\/6 nephrectomized rats. Nephrol Dial Transplant1993; 8: 1338\u20131343"},{"key":"key\n\t\t\t\t20180110092209_R11","doi-asserted-by":"crossref","unstructured":"O'Donnell MP, Kasiske BL, Kim Y, Schmitz PG, Keane WF. Lovastatin retards the progression of established glomerular disease in obese Zucker rats. Am J Kidney Dis1993; 22: 83\u201393","DOI":"10.1016\/S0272-6386(12)70172-5"},{"key":"key\n\t\t\t\t20180110092209_R12","doi-asserted-by":"crossref","unstructured":"Glazer AA, Inman SR, Stowe NT, Novick AC. Renal microcirculatory effects of lovastatin in a rat model of reduced renal mass. Urology1997; 50: 812\u2013817","DOI":"10.1016\/S0090-4295(97)00338-5"},{"key":"key\n\t\t\t\t20180110092209_R13","doi-asserted-by":"crossref","unstructured":"Gile RD, Cowley BD, Gattone VH, O'Donnell MP, Swan SK, Grantham JJ. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat. Am J Kidney Dis1995; 26: 501\u2013507","DOI":"10.1016\/0272-6386(95)90497-2"},{"key":"key\n\t\t\t\t20180110092209_R14","doi-asserted-by":"crossref","unstructured":"Hafez KS, Inman SR, Stowe NT, Novick AC. Renal hemodynamic effects of lovastatin in a renal ablation model. Urology1996; 48: 862\u2013867","DOI":"10.1016\/S0090-4295(96)00314-7"},{"key":"key\n\t\t\t\t20180110092209_R15","doi-asserted-by":"crossref","unstructured":"Jiang J, Sun CW, Alonsogalicia N, Roman RJ. Lovastatin reduces renal vascular reactivity in spontaneously hypertensive rats. Am J Hypertens1998; 11: 1222\u20131231","DOI":"10.1016\/S0895-7061(98)00143-5"},{"key":"key\n\t\t\t\t20180110092209_R16","doi-asserted-by":"crossref","unstructured":"Jiang J, Roman RJ. Lovastatin prevents development of hypertension in spontaneously hypertensive rats. Hypertension1997; 30: 968\u2013974","DOI":"10.1161\/01.HYP.30.4.968"},{"key":"key\n\t\t\t\t20180110092209_R17","doi-asserted-by":"crossref","unstructured":"Stroes E, Koomans H, de Bruin T, Rabelink T. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid\u2010lowering medication. Lancet1995; 346: 467\u2013471","DOI":"10.1016\/S0140-6736(95)91322-X"},{"key":"key\n\t\t\t\t20180110092209_R18","doi-asserted-by":"crossref","unstructured":"O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG\u2010coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation1997; 95: 1126\u20131131","DOI":"10.1161\/01.CIR.95.5.1126"},{"key":"key\n\t\t\t\t20180110092209_R19","unstructured":"O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF. The mevalonate pathway: importance in mesangial cell biology and glomerular disease. Miner Electrolyte Metab1993; 19: 173\u2013179"},{"key":"key\n\t\t\t\t20180110092209_R20","doi-asserted-by":"crossref","unstructured":"O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF. Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest1993; 91: 83\u201387","DOI":"10.1172\/JCI116204"},{"key":"key\n\t\t\t\t20180110092209_R21","doi-asserted-by":"crossref","unstructured":"Rovin BH, Tan LC. LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int1993; 43: 218\u2013225","DOI":"10.1038\/ki.1993.35"},{"key":"key\n\t\t\t\t20180110092209_R22","doi-asserted-by":"crossref","unstructured":"Nogaki F, Muso E, Yashiro M et al. Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells. Kidney Int1999; 71: S198\u2013S201","DOI":"10.1046\/j.1523-1755.1999.07151.x"},{"key":"key\n\t\t\t\t20180110092209_R23","doi-asserted-by":"crossref","unstructured":"Iimura O, Vrtovsnik F, Terzi F, Friedlander G. HMG\u2010CoA reductase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture. Kidney Int1997; 52: 962\u2013972","DOI":"10.1038\/ki.1997.418"},{"key":"key\n\t\t\t\t20180110092209_R24","doi-asserted-by":"crossref","unstructured":"Kaesemeyer WH, Caldwell RB, Huang J, Caldwell RW. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol\u2010lowering actions. J Am Coll Cardiol1999; 33: 234\u2013241","DOI":"10.1016\/S0735-1097(98)00514-2"},{"key":"key\n\t\t\t\t20180110092209_R25","doi-asserted-by":"crossref","unstructured":"Laufs U, Lafata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation1998; 97: 1129\u20131135","DOI":"10.1161\/01.CIR.97.12.1129"},{"key":"key\n\t\t\t\t20180110092209_R26","doi-asserted-by":"crossref","unstructured":"Chang PC, Verlinde R, Bruning TA, Van Brummelen P. A microcomputer\u2010based, R\u2010wave triggered system for hemodynamic measurements in the forearm. Comput Biol Med1988; 18: 157\u2013163","DOI":"10.1016\/0010-4825(88)90042-X"},{"key":"key\n\t\t\t\t20180110092209_R27","doi-asserted-by":"crossref","unstructured":"Kamper AM, Chang PC. Effects of arm dominance and brachial artery cannulation on forearm blood flow measured by strain\u2010gauge plethysmography. Clin Sci1999; 97: 539\u2013546","DOI":"10.1042\/cs0970539"},{"key":"key\n\t\t\t\t20180110092209_R28","doi-asserted-by":"crossref","unstructured":"Cole BR, Giangiacomo J, Ingelfinger JR, Robson AM. Measurement of renal function without urine collection: a critical evaluation of the constant\u2010infusion technique for determination of inulin and para\u2010aminohippurate. New Engl J Med1972; 287: 1109\u20131114","DOI":"10.1056\/NEJM197211302872202"},{"key":"key\n\t\t\t\t20180110092209_R29","doi-asserted-by":"crossref","unstructured":"Stowe NT, Inman SR, Tapolyai M, Brouhard BH, Hodge EE, Novick AC. Lovastatin has direct renal hemodynamic effects in a rodent model. J Urol1996; 156: 249\u2013252","DOI":"10.1016\/S0022-5347(01)66010-5"},{"key":"key\n\t\t\t\t20180110092209_R30","doi-asserted-by":"crossref","unstructured":"Bjork S, Mulec H, Johnsen SA, Norden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. Br Med J1992; 304: 339\u2013343","DOI":"10.1136\/bmj.304.6823.339"},{"key":"key\n\t\t\t\t20180110092209_R31","doi-asserted-by":"crossref","unstructured":"Majmudar NG, Robson SC, Ford GA. Effects of the menopause, gender and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab2000; 85: 1577\u20131583","DOI":"10.1210\/jcem.85.4.6530"},{"key":"key\n\t\t\t\t20180110092209_R32","doi-asserted-by":"crossref","unstructured":"Wang D, Iversen J, Strandgaard S. Endothelium\u2010dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol2000; 11: 1371\u20131376","DOI":"10.1681\/ASN.V1181371"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/16\/11\/2152\/23368834\/162152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T17:00:48Z","timestamp":1621270848000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/16\/11\/2152\/1932971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2001,11]]},"published-print":{"date-parts":[[2001,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/16.11.2152","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,11]]},"published":{"date-parts":[[2001,11,1]]}}}